Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1387.60
4.60 (0.33%) Cipla - Quaterly Results
Date: 24-01-2026
A decrease in the sales to Rs. 44980.80 millions was observed for the quarter ended December 2025. The sales stood at Rs. 49708.80 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 6168.80 millions from Rs. 14381.50 millions, a decline of -57.11% on QoQ basis.The company reported a degrowth in operating Profit to 11379.00 millions from 18505.20 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202512 | 202412 | % Var | 202512 | 202412 | % Var | 202503 | 202403 | % Var | |
| Sales | 44980.80 | 49708.80 | -9.51 | 147699.70 | 142469.60 | 3.67 | 190448.50 | 165743.40 | 14.91 |
| Other Income | 4167.00 | 1886.90 | 120.84 | 9424.30 | 6913.50 | 36.32 | 9847.20 | 10706.60 | -8.03 |
| PBIDT | 11379.00 | 18505.20 | -38.51 | 48107.10 | 51510.80 | -6.61 | 67631.60 | 55548.10 | 21.75 |
| Interest | 40.30 | 35.50 | 13.52 | 125.60 | 116.20 | 8.09 | 151.10 | 202.50 | -25.38 |
| PBDT | 8895.00 | 18469.70 | -51.84 | 45537.80 | 51394.60 | -11.40 | 70427.10 | 55345.60 | 27.25 |
| Depreciation | 1533.30 | 1426.20 | 7.51 | 4403.20 | 4261.90 | 3.32 | 5738.90 | 5875.90 | -2.33 |
| PBT | 7361.70 | 17043.50 | -56.81 | 41134.60 | 47132.70 | -12.73 | 64688.20 | 49469.70 | 30.76 |
| TAX | 1192.90 | 2662.00 | -55.19 | 9829.20 | 10410.20 | -5.58 | 13111.70 | 12327.80 | 6.36 |
| Deferred Tax | 54.20 | 32.40 | 67.28 | 7.90 | 134.10 | -94.11 | -491.50 | 60.90 | -907.06 |
| PAT | 6168.80 | 14381.50 | -57.11 | 31305.40 | 36722.50 | -14.75 | 51576.50 | 37141.90 | 38.86 |
| Equity | 1615.50 | 1615.20 | 0.02 | 1615.50 | 1615.20 | 0.02 | 1615.20 | 1614.70 | 0.03 |
| PBIDTM(%) | 25.30 | 37.23 | -32.05 | 32.57 | 36.16 | -9.91 | 35.51 | 33.51 | 5.96 |